Save time and money with
Med Tech Market Research


MedTech Business intelligence
supplied through Trade Tracker, Research and Markets and GlobalData

Diagnostics


Report title Date Pages Price
(approx)
Molecular Diagnostics Nov 2010 975 £3130
Indian Diagnostic Market Analysis Oct 2010 50 £500
Molecular Diagnostics Markets Oct 2010 272 £2130

Reports available from Global Data

Report title Date Pages Single user price
United States In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 261 $2,500
United Kingdom In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 213 $2,500
Canada In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 205 $2,500
Italy In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 186 $2,500
Spain In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 193 $2,500
Brazil In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 186 $2,500
Netherlands In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 205 $2,500
Republic of Korea In Vitro Diagnostics Market Outlook to 2016 29-Jul-2010 191 $2,500

The Worldwide Market for Cancer Diagnostics. 4th Edition
This report authored by Kalorama Diagnostic Analyst Shara Rosen, contains detailed market data on the following IVD segments for their use in cancer diagnostics: Histology/Cytology, Immunoassays, Flow Cytometry, Rapid Tests, Molecular Assays, Tissue Arrays, Circulating Tumor Cells, Pharmacodiagnostics. April 2010

In Vitro Diagnostics in a Recession
It is commonly asserted that in vitro diagnostics is a recession-proof industry. This report tests that assumption: What impact is the downturn having on in vitro diagnostic companies? What are the best areas of IVD and the best world markets? How should companies price and market their products? What are key companies in the market doing at this time? May 2009 more ...

Top Ten Global In-Vitro Diagnostics Companies
The global in-vitro diagnostics (IVD) market is forecast to grow at a rate of 6% to reach $50.0bn in 2012. Roche is the largest player in the market with a share of 20%. It is followed by Siemens and Abbott, who both hold 12% of the market. The IVD market is highly consolidated, with the top ten players holding close to 80% market share. A number of large in-vivo players have entered the IVD market recently, signalling the convergence of the two diagnostic fields. Siemens Healthcare is a prominent example of this trend, following their acquisition of DPC, Bayer Diagnostics and Dade Behring. more ...

Point of Care Diagnostic Testing. World Markets
The report describes the specific market segment of the in vitro diagnostics market called point-of-care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized in near-patient environments like hospitals, clinics and doctor's offices. The study defines the dollar volume of sales, both worldwide and in the US, and analyzes the factors that influence the size and the growth of the market segments. more ...

 

To top